CytomX Therapeutics Inc (CTMX) Insider Trading
- $7,816,720.00
- $50,438,599.91
- Aug. 20, 2024
- Sean A Mccarthy
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Jan. 5, 2018 | Director | 10,000 | $25.01 | Sell | $250,100.00 | |
Jan. 2, 2018 | Insider | 13,052 | $21.04 | Sell | $274,614.08 | |
Jan. 2, 2018 | CFO | 2,500 | $21.11 | Sell | $52,775.00 | |
Dec. 26, 2017 | Director | 5,000 | $22.29 | Sell | $111,450.00 | |
Dec. 1, 2017 | CFO | 2,500 | $20.58 | Sell | $51,450.00 | |
Dec. 1, 2017 | Insider | 14,340 | $20.60 | Sell | $295,404.00 | |
Nov. 1, 2017 | CFO | 2,500 | $20.00 | Sell | $50,000.00 | |
Nov. 1, 2017 | CEO | 14,342 | $19.86 | Sell | $284,832.12 | |
Oct. 4, 2017 | Major Shareholder | 24,777 | $24.34 | Sell | $603,072.18 | |
Oct. 4, 2017 | CEO | 19,120 | $24.13 | Sell | $461,365.60 | |
Oct. 4, 2017 | Insider | 48,368 | $24.34 | Sell | $1,177,277.12 | |
Oct. 4, 2017 | Director | 10,000 | $24.27 | Sell | $242,700.00 | |
Oct. 2, 2017 | CFO | 2,500 | $18.10 | Sell | $45,250.00 | |
Oct. 2, 2017 | Insider | 9,562 | $18.57 | Sell | $177,566.34 | |
Sept. 26, 2017 | Director | 5,000 | $17.30 | Sell | $86,500.00 | |
Sept. 19, 2017 | Major Shareholder | 20,000 | $18.00 | Sell | $360,000.00 | |
Sept. 1, 2017 | Insider | 9,930 | $17.32 | Sell | $171,987.60 | |
Sept. 1, 2017 | CFO | 2,500 | $17.17 | Sell | $42,925.00 | |
Aug. 31, 2017 | Insider | 18,756 | $17.50 | Sell | $328,230.00 | |
Aug. 9, 2017 | CFO | 2,500 | $15.00 | Sell | $37,500.00 | |
Aug. 9, 2017 | Insider | 4,781 | $15.00 | Sell | $71,715.00 | |
July 3, 2017 | CFO | 2,500 | $15.47 | Sell | $38,675.00 | |
July 3, 2017 | Insider | 4,781 | $15.52 | Sell | $74,201.12 | |
June 29, 2017 | Major Shareholder | 15,000 | $16.00 | Sell | $240,000.00 | |
June 26, 2017 | Insider | 4,481 | $15.00 | Sell | $67,215.00 | |
June 26, 2017 | Director | 5,000 | $14.61 | Sell | $73,050.00 | |
June 5, 2017 | Insider | 300 | $15.00 | Sell | $4,500.00 | |
May 1, 2017 | Insider | 4,781 | $15.70 | Sell | $75,061.70 | |
April 12, 2017 | Major Shareholder | 28,357 | $16.36 | Sell | $463,920.52 | |
April 4, 2017 | Insider | 9,562 | $17.22 | Sell | $164,657.64 | |
March 27, 2017 | Major Shareholder | 1,650,000 | $17.39 | Sell | $28,693,500.00 | |
March 20, 2017 | Insider | 14,343 | $19.60 | Sell | $281,122.80 | |
March 20, 2017 | CFO | 21,517 | $19.81 | Sell | $426,251.77 | |
March 3, 2017 | Insider | 14,343 | $15.00 | Sell | $215,145.00 | |
Nov. 28, 2016 | Director | 38,459 | $11.56 | Sell | $444,586.04 | |
Nov. 22, 2016 | Director | 42,550 | $11.71 | Sell | $498,260.50 | |
Nov. 21, 2016 | Director | 45,324 | $11.61 | Sell | $526,211.64 | |
Nov. 16, 2016 | Director | 51,581 | $11.50 | Sell | $593,181.50 | |
Nov. 15, 2016 | Director | 33,064 | $11.48 | Sell | $379,574.72 | |
Nov. 14, 2016 | Director | 86,270 | $11.16 | Sell | $962,773.20 | |
Nov. 9, 2016 | Director | 13,730 | $11.03 | Sell | $151,441.90 | |
June 10, 2016 | Director | 48,427 | $10.07 | Sell | $487,659.89 | |
June 7, 2016 | Director | 111,498 | $10.01 | Sell | $1,116,094.98 | |
June 3, 2016 | Director | 59,621 | $10.80 | Sell | $643,906.80 | |
June 1, 2016 | Director | 22,463 | $10.75 | Sell | $241,477.25 | |
May 27, 2016 | Director | 25,082 | $10.60 | Sell | $265,869.20 | |
May 26, 2016 | Director | 51,343 | $10.34 | Sell | $530,886.62 | |
May 24, 2016 | Director | 13,253 | $10.09 | Sell | $133,722.77 | |
May 20, 2016 | Director | 8,687 | $10.10 | Sell | $87,738.70 | |
Oct. 14, 2015 | Insider | 625,000 | $12.00 | Buy | $7,500,000.00 |
Insiders are both buying and selling CytomX Therapeutics Inc stock.
The insider traders at CytomX Therapeutics Inc are: Sean A Mccarthy, Debanjan Ray, Ix L.P. Canaan, Frederick W Gluck, Lloyd A Rowland, Robert I Tepper, Timothy M Shannon, Christopher Ogden, Jeffrey B Landau, Marcia Belvin, Amy C Peterson, Carlos Campoy, Rachel Humphrey, William Michael Kavanaugh, Cynthia J Ladd, Elaine V Jones, James E Flynn, Kevin P Starr, Robert C Goeltz II, Rock Ventures Lp Third, and Sean A. Mccarthy
The most active insider trader at CytomX Therapeutics Inc is Sean A Mccarthy with 30 trades.
Rock Ventures Lp Third has sold the most CytomX Therapeutics Inc stock with a total value of $57,387,000.00.
James E Flynn has bought the most CytomX Therapeutics Inc stock with a total value of $15,000,000.00.
The most recent insider trade for CytomX Therapeutics Inc was on Aug. 20, 2024.
The single biggest insider buy for CytomX Therapeutics Inc was from James E Flynn with a total value of $7,500,000.00 on Oct. 14, 2015.
The single biggest insider sell for CytomX Therapeutics Inc was from Rock Ventures Lp Third with a total value of $28,693,500.00 on March 27, 2017.